Display options
Cite
Sweet DE. Initial Antiretroviral Therapy: When and With What to Begin. Top HIV Med. 2002;10(5):4-9
Sweet, D. E. (2002). Initial Antiretroviral Therapy: When and With What to Begin. Topics in HIV medicine : a publication of the International AIDS Society, USA, 10(5), 4-9.
Sweet, Donna E.. "Initial Antiretroviral Therapy: When and With What to Begin." Topics in HIV medicine : a publication of the International AIDS Society, USA vol. 10,5 (2002): 4-9.
Sweet DE. Initial Antiretroviral Therapy: When and With What to Begin. Top HIV Med. 2002 Nov-Dec;10(5):4-9. PMID: 12717049.
Copy Download .nbib Format: NLM
Share it on

Top HIV Med. 2002 Nov-Dec;10(5):4-9.

Initial Antiretroviral Therapy: When and With What to Begin.

Topics in HIV medicine : a publication of the International AIDS Society, USA

Donna E. Sweet

Affiliations

  1. University of Kansas School of Medicine, Wichita, KS, USA.

PMID: 12717049

Abstract

At the International AIDS Society-USA course in Denver in May 2002, Donna E. Sweet, MD, discussed issues related to the ongoing question of when to initiate antiretroviral therapy in HIV-infected individuals and factors in selecting an initial drug regimen. Current treatment guidelines offer some consensus on the question of timing. Selection of the initial therapy focuses on the choice between regimens based on nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, or protease inhibitors.

Publication Types